This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chiappetta, G. Articles by Fusco, A. Search for Related Content PubMed PubMed Citation Articles by Chiappetta, G. Articles by Fusco, A.

The RET/PTC Oncogene Is Frequently Activated in Oncocytic Thyroid Tumors (Hurthle Cell Adenomas and Carcinomas), but Not in Oncocytic Hyperplastic Lesions

Istituto Nazionale dei Tumori di Napoli (G.C., A.G., I.A., M.M.), Fondazione Senatore Pascale, 80131 Napoli, Italy; Istituto di Anatomia Patologica (P.Tot., S.L., P.Tos.), Università degli Studi di Siena, Nuovo Policlinico, 53100 Siena, Italy; Istituto di Clinica Chirurgica (F.C.), Università degli Studi di Siena, Nuovo Policlinico, 53100 Siena, Italy; Centro di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche (F.P., I.A., M.S., A.F.), Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università di Napoli "Federico II," 80131 Naples, Italy; Institute of Pathology (L.M.), University of Bern, CH-3010 Bern, Switzerland

Address all correspondence and requests for reprints to: Alfredo Fusco, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli "Federico II", via Pansini 5, 80131 Naples, Italy. E-mail: afusco{at}napoli.com

Hurthle cell adenomas and carcinomas, characterized by the presence of oncocytic cells, are unusual thyroid neoplasms, the treatment of which is still controversial. We analyzed specimens from 49 patients with oncocytic cell nodular lesions including 20 adenomas, 19 carcinomas, and 10 hyperplasias for RET/PTC (papillary thyroid carcinoma) activation, which is the most frequent genetic alteration in PTCs. RET/PTC activation was detected in a significant number of cases of Hurthle cell adenomas and carcinomas, but in 0 of 10 patients with hyperplastic nodules. In particular, the RET/PTC1 isoform was found in 7 of 12 adenomas and 4 of 7 carcinomas. These results would indicate that RET/PTC is a genetic event common to papillary carcinomas and to Hurthle cell neoplasias.

This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (Progetto Speciale Oncosoppressori), the Progetto Finalizzato "Biotecnologie" of the Consiglio Nazionale delle Ricerche, Telethon projects E611 and E1123, the Ministero dell’Università e della Ricerca Scientifica e Tecnologica projects "Terapie antineoplastiche innovative" and "Piani di Potenziamento della Rete Scientifica e Tecnologica", and the "Ministero della Sanità".

Abbreviations: PTC, Papillary thyroid carcinoma.

This article has been cited by other articles:

				Z. V. Maizlin, S. M. Wiseman, P. Vora, J. M. Kirby, A. C. Mason, D. Filipenko, and J. A. Brown Hurthle Cell Neoplasms of the Thyroid: Sonographic Appearance and Histologic Characteristics J. Ultrasound Med., May 1, 2008; 27(5): 751 - 757. [Abstract] [Full Text] [PDF]

				M. Santoro, R. M. Melillo, and A. Fusco RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur. J. Endocrinol., November 1, 2006; 155(5): 645 - 653. [Abstract] [Full Text] [PDF]

				Z. Zhu, R. Ciampi, M. N. Nikiforova, M. Gandhi, and Y. E. Nikiforov Prevalence of RET/PTC Rearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3603 - 3610. [Abstract] [Full Text] [PDF]

				J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors Endocr. Rev., August 1, 2006; 27(5): 535 - 560. [Abstract] [Full Text] [PDF]

				Y. E. Nikiforov RET/PTC Rearrangement--A Link between Hashimoto's Thyroiditis and Thyroid Cancer...or Not J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2040 - 2042. [Full Text] [PDF]

				F. Weber, L. Shen, M. A. Aldred, C. D. Morrison, A. Frilling, M. Saji, F. Schuppert, C. E. Broelsch, M. D. Ringel, and C. Eng Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2512 - 2521. [Abstract] [Full Text] [PDF]

				K. T. Mai, G. Elmontaser, D. G. Perkins, J. Thomas, and W. A. Stinson Benign Hurthle Cell Adenoma with Papillary Architecture: A Benign Lesion Mimicking Oncocytic Papillary Carcinoma International Journal of Surgical Pathology, January 1, 2005; 13(1): 37 - 41. [Abstract] [PDF]

				S. Sadetzki, R. Calderon-Margalit, B. Modan, S. Srivastava, and R. M. Tuttle Ret/PTC Activation in Benign and Malignant Thyroid Tumors Arising in a Population Exposed to Low-Dose External-Beam Irradiation in Childhood J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2281 - 2289. [Abstract] [Full Text] [PDF]

				S L Asa My approach to oncocytic tumours of the thyroid J. Clin. Pathol., March 1, 2004; 57(3): 225 - 232. [Abstract] [Full Text] [PDF]

				C. A. French, E. K. Alexander, E. S. Cibas, V. Nose, J. Laguette, W. Faquin, J. Garber, F. Moore Jr, J. A. Fletcher, P. R. Larsen, et al. Genetic and Biological Subgroups of Low-Stage Follicular Thyroid Cancer Am. J. Pathol., April 1, 2003; 162(4): 1053 - 1060. [Abstract] [Full Text] [PDF]

				T. G. Kroll Molecular Rearrangements and Morphology in Thyroid Cancer Am. J. Pathol., June 1, 2002; 160(6): 1941 - 1944. [Full Text] [PDF]